Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 22Melanoma 6Histiocytoma, Malignant Fibrous 6Gastrointestinal Stromal Tumors 5Osteosarcoma 4Neoplasm Metastasis 4Gliosarcoma 4Neuroblastoma 3Hemangiosarcoma 3Chordoma 3Bone Neoplasms 3Wilms Tumor 2Triple Negative Breast Neoplasms 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Nasopharyngeal Carcinoma 2Lymphoma 2Lung Neoplasms 2Liver Neoplasms 2Liposarcoma 2Head and Neck Neoplasms 2Glioblastoma 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Bile Duct Neoplasms 2

Interventions

Doxorubicin 17Cyclophosphamide 16Ifosfamide 11fludarabine 9Radiotherapy 8tazemetostat 5pembrolizumab 4pazopanib 4Gemcitabine 4pegfilgrastim 3cixutumumab 3Trabectedin 3Radiation 3Imatinib Mesylate 3Filgrastim 3Docetaxel 3Dacarbazine 3sargramostim 2liposomal doxorubicin 2fludarabine phosphate 2brostallicin 2aldesleukin 2X-Rays 2Sunitinib 2Specimen Handling 2Sorafenib 2Radiation Dose Hypofractionation 2Quality of Life 2Nivolumab 2Molecular Diagnostic Techniques 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × Ipilimumab × Sarcoma × Clear all
NCT00140855 2022-10-12

A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma

Ludwig Institute for Cancer Research

Phase 2 Terminated
6 enrolled 8 charts
Sarcoma

Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡